Tau protein can be measured in cerebrospinal fluid (CSF) as total tau (T-tau), which is increased in AD and other neurological diseases, and as phosphorylated tau (P-tau181), which is specifically increased in AD; Aβ42, on the other hand, shows decreased CSF levels [1]. Here, MAPT is linked to Alzheimer disease.